Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Other Accumulated Expenses (2018 - 2026)

Updated

Outlook Therapeutics' Other Accumulated Expenses came in at $220,158 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 83.2% from $1.31 million a year earlier and down 95.0% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Other Accumulated Expenses was $1.19 million, up 209.1% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of -16.3% (FY2020 to FY2025).
  • Going back by fiscal year, Other Accumulated Expenses was $384,366 in FY2024 (-68.9%), $1.23 million in FY2023 (+65.9%), $744,154 in FY2022 (-8.0%) and $808,780 in FY2021 (-72.0%).
  • The fiscal Q3 2026 figure represents the lowest quarterly Other Accumulated Expenses in data going back to fiscal Q4 2018.
  • Year-over-year, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 117.6%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in fiscal Q2 2026 (growth of 395.9%), and the weakest in fiscal Q3 2024 (a decline of 92.5%).
  • Business Quant data shows OTLK's Other Accumulated Expenses at $4.44 million (Q2 2026), $1.05 million (Q1 2026) and $1.19 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220,158.00
Mar 31, 2026 4.44 Mn
Dec 31, 2025 1.05 Mn
Sep 30, 2025 1.19 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 896,249.00
Dec 31, 2024 276,958.00
Sep 30, 2024 384,366.00
Jun 30, 2024 399,853.00
Mar 31, 2024 544,562.00
Dec 31, 2023 1.63 Mn
Sep 30, 2023 1.23 Mn
Jun 30, 2023 5.33 Mn
Mar 31, 2023 3.84 Mn
Dec 31, 2022 1.23 Mn
Sep 30, 2022 744,154.00
Jun 30, 2022 1.46 Mn
Mar 31, 2022 1.15 Mn
Dec 31, 2021 1.38 Mn
Sep 30, 2021 808,780.00
API Access

Outlook Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY